Sutro Biopharma
Andrew T. Mason currently serves as the Director of Compliance QA at Exelixis, a position held since December 2024. Prior to this, Andrew Mason accumulated extensive experience at Sutro Biopharma, Inc., progressing through various roles from Sr. Director to Associate Director in External Quality Assurance from April 2019. Andrew Mason's career began at Genentech, where a span of nearly two decades included positions such as Compliance Manager and Business Analyst II/Compliance Auditor. Earlier experience included a role as a Research Associate at Mendel Biological Solutions. Andrew Mason holds an MBA in Business Administration and Management from Golden Gate University and a B.Sc. in Biological Sciences from California State University - East Bay.
This person is not in any teams
This person is not in any offices
Sutro Biopharma
3 followers
Sutro Biopharma is developing a new generation of multi-functional antibody drug conjugate therapeutics and bifunctional antibody-based therapeutics for targeted cancer therapies.